艾滋病。逃离免疫系统。 - Suppr

Suppr

超能文献

AIDS. Escape from the immune system.

作者信息

Walker B D, Goulder P J

出版信息

Nature. 2000 Sep 21;407(6802):313-4. doi: 10.1038/35030283.

DOI:10.1038/35030283

PMID:11014174

Abstract

摘要

相似文献

AIDS. Escape from the immune system.

Nature. 2000 Sep 21;407(6802):313-4. doi: 10.1038/35030283.

Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.

J Virol. 2005 Oct;79(19):12321-31. doi: 10.1128/JVI.79.19.12321-12331.2005.

New finding on immune response to HIV Tat may contribute to vaccine, treatment.

AIDS Treat News. 2000 Sep 22(351):4.

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.

Nature. 2000 Sep 21;407(6802):386-90. doi: 10.1038/35030124.

Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).

Virology. 2001 Jan 5;279(1):241-56. doi: 10.1006/viro.2000.0695.

CTL ontogeny and viral escape: implications for HIV-1 vaccine design.

Trends Immunol. 2004 Mar;25(3):138-42. doi: 10.1016/j.it.2004.01.004.

HIV and SIV CTL escape: implications for vaccine design.

Nat Rev Immunol. 2004 Aug;4(8):630-40. doi: 10.1038/nri1417.

Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.

Vaccine. 2004 Sep 3;22(25-26):3258-69. doi: 10.1016/j.vaccine.2004.03.009.

Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P cy243 epitope variability.

Virus Genes. 2008 Feb;36(1):105-15. doi: 10.1007/s11262-007-0179-8. Epub 2007 Nov 30.

A peptide-loaded dendritic cell based cytotoxic T-lymphocyte (CTL) vaccination strategy using peptides that span SIV Tat, Rev, and Env overlapping reading frames.

Retrovirology. 2006 Jan 6;3:1. doi: 10.1186/1742-4690-3-1.

引用本文的文献

Mechanistic Models Predict Efficacy of CCR5-Deficient Stem Cell Transplants in HIV Patient Populations.

CPT Pharmacometrics Syst Pharmacol. 2016 Feb;5(2):82-90. doi: 10.1002/psp4.12059. Epub 2016 Feb 16.

Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges.

PLoS Pathog. 2011 May;7(5):e1002041. doi: 10.1371/journal.ppat.1002041. Epub 2011 May 19.

Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag.

AIDS. 2009 Apr 27;23(7):771-7. doi: 10.1097/QAD.0b013e32832995e0.

The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.

AIDS Res Hum Retroviruses. 2008 Oct;24(10):1285-90. doi: 10.1089/aid.2008.0072.

Design and pre-clinical evaluation of a universal HIV-1 vaccine.

PLoS One. 2007 Oct 3;2(10):e984. doi: 10.1371/journal.pone.0000984.

CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques.

J Virol. 2007 Dec;81(24):13865-75. doi: 10.1128/JVI.00452-07. Epub 2007 Sep 26.

Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?

J Neurovirol. 2005 Apr;11(2):107-28. doi: 10.1080/13550280590922838.

Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.

J Virol. 2003 Dec;77(24):13248-56. doi: 10.1128/jvi.77.24.13248-13256.2003.

Widespread adaptive evolution in the human immunodeficiency virus type 1 genome.

J Mol Evol. 2003 Aug;57(2):212-21. doi: 10.1007/s00239-003-2467-9.

Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.

J Virol. 2003 Jul;77(13):7330-40. doi: 10.1128/jvi.77.13.7330-7340.2003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验